Peramivir Market Growth, Trends & Forecast by 2034

Coverage: By Type (Solution, Solid); Application (Influenza A Treatment, Influenza B Treatment), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00014944
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : April 28, 2026
Peramivir Market Growth, Trends & Forecast by 2034
Report Date: April 28, 2026   |   Report Code: TIPRE00014944 Email: sales@theinsightpartners.com

2025 Market Size

US$ 135.92 Mn

Base year value

2034 Forecast

US$ 335.48 Mn

Projected by 2034

CAGR 2026-2034

10.56 %

Growth rate

Addressable Market

US$ 2,089.32 Mn

(2026-2034)

The Peramivir Market size is expected to reach US$ 335.48 Million by 2034 from US$ 135.92 Million in 2025. The market is estimated to record a CAGR of 10.56% from 2026 to 2034.

The Peramivir Market report is segmented by type into Solution and Solid. The application segment includes Influenza A Treatment and Influenza B Treatment. The market evaluation is presented in US$ for the above segmental analysis. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.

Purpose of the Report

The report Peramivir Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Peramivir Market Segmentation

Type

  1. Solution
  2. Solid

Application

  1. Influenza A Treatment
  2. Influenza B Treatment

Market Assessment and Insights

  • Global market for Peramivir was valued at US$ 135.92 Million in 2025
  • Annual market size is expected to reach US$ 335.48 Million by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 2,089.32 Million
  • Market is anticipated to register a CAGR of 10.56% during the forecast period
  • The United States represents a key market, supported by Growing Trend of Influenza Seasonality, Advancements in Healthcare Infrastructure and Awareness, Efficacy in Treating Severe Influenza Cases, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Rising Incidence of Influenza Among Vulnerable Populations, Prophylactic Use in High-Risk Settings, Research and Development in Formulation and Combination Therapies are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Green Cross Pharma, Shionogi Co., Neopharm, Moksha8 Pharma, NT Pharma, Merck, Hikma Pharmaceuticals, Hunan Nucien Pharmaceutical Co., Ltd., SCOLR Pharma, BioCryst Pharmaceuticals, Inc., while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Peramivir Market: Strategic Insights

peramivir-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Peramivir Market Growth Drivers

  1. Growing Trend of Influenza Seasonality: It has fairly established the effectiveness of this drug in curing influenza as well as more severe ones. As such, the number of the geriatric population susceptible to influenza resulting in serious infections will create more market demand.
  2. Advancements in Healthcare Infrastructure and Awareness: Improvements in healthcare infrastructures and increasing awareness towards preventing and treating influenza have created momentum in the market.
  3. Efficacy in Treating Severe Influenza Cases: Peramivir's ability to provide rapid relief through intravenous administration makes it a preferred option for hospitalized patients with severe influenza. Research on peramivir is under way for it to explore further antiviral use in general; therefore, the market of this medicine is most probably to grow constantly in the short-term period.

Peramivir Market Future Trends

  1. Pandemic Preparedness: As the world is gradually aware of the potential for pandemics in the future, it is expected that more antiviral medications with higher efficacy than peramivir will be needed.
  2. R&D Advancements in Peramivir: More R&D work is going into peramivir in formulating and delivery technology for better efficacy and better patient compliance.
  3. Prophylactic Use of Peramivir: More scope of market growth can also be realized by considering peramivir as a prophylactic agent.

Peramivir Market Opportunities

  1. Rising Incidence of Influenza Among Vulnerable Populations: The incidence of influenza is rapidly rising among the elderly and immunocompromised patients, and, thus, there is significant demand for effective antiviral treatments.
  2. Prophylactic Use in High-Risk Settings: Another area with a huge market potential relates to the prophylactic use of peramivir, especially in high-risk settings like hospitals and nursing homes.
  3. Research and Development in Formulation and Combination Therapies: More research and development work into enhancing the formulation, delivery, and combination therapies with other antiviral drugs could open up more applications for peramivir.

Peramivir Market Report Scope

Report Attribute Details
Market size in 2025 US$ 135.92 Million
Market Size by 2034 US$ 335.48 Million
Global CAGR (2026 - 2034) 10.56%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Type
  • Solution
  • Solid
By Application
  • Influenza A Treatment
  • Influenza B Treatment
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Green Cross Pharma
  • Shionogi Co.
  • Neopharm
  • Moksha8 Pharma
  • NT Pharma
  • Merck
  • Hikma Pharmaceuticals
  • Hunan Nucien Pharmaceutical Co., Ltd.
  • SCOLR Pharma
  • BioCryst Pharmaceuticals, Inc.

Peramivir Market Players Density: Understanding Its Impact on Business Dynamics

The Peramivir Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

peramivir-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Peramivir Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Peramivir Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

The leading players of the market are: Green Cross Pharma, Shionogi Co., Neopharm, Moksha8 Pharma, NT Pharma, Merck, Hikma Pharmaceuticals, Hunan Nucien Pharmaceutical Co., Ltd., SCOLR Pharma, BioCryst Pharmaceuticals, Inc.

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

The future of the peramivir market is bright, with several emerging trends. One of the most important trends is the increasing focus on pandemic preparedness. As the world develops an increased awareness of the possibility for future pandemics, more demand for effective antiviral drugs such as peramivir will certainly be seen. Furthermore, present research and development is continuing to work on formulating and delivering peramivir in a better fashion, which may bring a better response and adherence rate in patients. In addition, the prophylactic potential of peramivir is also under scrutiny, which will create some more opportunities for growth. However, long-term trend of the peramivir market may be affected by challenges such as the emergence of drug-resistant influenza strains and development of new antiviral agents.

Peramivir Market is expected to grow at a CAGR of 10.56% from 2026 to 2034

Several factors drive the peramivir market. Primarily, the increasing number of influenza cases, more significantly during seasonal outbreaks, forms a major driver. Since the drug is effective for severe cases of influenza, its importance in treatment cannot be denied. Moreover, with the increase in geriatric population, which tends to be more vulnerable to such severe infections, drives demand in the market even more. In addition, the development of healthcare infrastructure and the awareness of prevention and treatment of influenza are factors that are driving the market forward. As research continues to explore the potential of peramivir in broader antiviral applications, the market is expected to see continued growth in the years ahead.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA